SHOULDER INNOVATIONS, INC. (SI)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SHOULDER INNOVATIONS, INC. (SI) trades at $14.30 with AI Score 59/100 (Hold). Shoulder Innovations, Inc. is a medical device company specializing in shoulder replacement systems. Founded in 2009, the company is headquartered in Grand Rapids, MI. Market cap: $295.26M, Sector: Healthcare.
Last analyzed: Feb 9, 2026SHOULDER INNOVATIONS, INC. (SI) Healthcare & Pipeline Overview
Shoulder Innovations offers innovative shoulder replacement systems, providing surgeons and patients with advanced solutions for improved outcomes and faster recovery. With a focus on biomechanics and patient-specific designs, SI is poised to capture significant market share in the orthopedic device sector.
Investment Thesis
Shoulder Innovations presents a notable research candidate due to its innovative shoulder replacement system and focus on patient-specific solutions. With a gross margin of 76.7%, the company demonstrates strong pricing power and efficient operations. While currently unprofitable with a P/E of -47.64 and a negative profit margin of -87.4%, the potential for rapid revenue growth and market share gains in the expanding orthopedic device market is significant. Key value drivers include increasing adoption of their advanced shoulder replacement system by orthopedic surgeons, expansion into new geographic markets, and potential for strategic partnerships or acquisitions. Upcoming catalysts include new product launches and positive clinical trial data expected in late 2026, which could drive significant stock appreciation. Investing in Shoulder Innovations offers exposure to a high-growth segment within the healthcare sector with a company poised to disrupt the traditional shoulder replacement market.
Based on FMP financials and quantitative analysis
Key Highlights
- Gross margin of 76.7% indicates strong pricing power and efficient manufacturing processes.
- Focus on patient-specific shoulder replacement systems differentiates them from competitors and caters to the growing demand for personalized medicine.
- Innovative product design aims to improve biomechanics and reduce complications, potentially leading to higher adoption rates among surgeons.
- Headquartered in Grand Rapids, MI, a growing hub for medical device innovation.
- Founded in 2009, the company has established a strong foundation in the orthopedic device market.
Competitors & Peers
Strengths
- Innovative shoulder replacement system with improved biomechanics.
- Focus on patient-specific solutions and personalized medicine.
- Strong gross margin of 76.7%.
- Experienced management team with expertise in medical devices.
Weaknesses
- Currently unprofitable with a negative profit margin of -87.4%.
- Relatively small market capitalization of $0.26B.
- Limited brand recognition compared to larger competitors.
- High beta of -7.48 indicates high volatility.
Catalysts
- Upcoming: Launch of new shoulder replacement system with enhanced features in Q4 2026.
- Upcoming: Positive clinical trial data demonstrating improved patient outcomes expected in Q3 2026.
- Ongoing: Increasing adoption of Shoulder Innovations' products by orthopedic surgeons.
- Ongoing: Expansion into new geographic markets and strategic partnerships.
Risks
- Potential: Competition from larger, more established players in the orthopedic device market.
- Potential: Regulatory hurdles and delays in obtaining approvals for new products.
- Ongoing: Negative profit margin and dependence on external financing.
- Ongoing: High beta indicates significant stock price volatility.
- Potential: Product liability claims and recalls.
Growth Opportunities
- Expansion into new geographic markets represents a significant growth opportunity for Shoulder Innovations. Currently focused on the United States, the company can leverage its innovative technology to penetrate international markets, particularly in Europe and Asia-Pacific, where demand for advanced orthopedic solutions is growing. This expansion could involve establishing distribution partnerships, securing regulatory approvals, and tailoring products to meet local market needs. The global market for shoulder replacement is estimated to reach $2 billion by 2028, providing a substantial addressable market for Shoulder Innovations.
- Development of new product lines and enhancements to existing shoulder replacement systems can drive revenue growth and market share gains. Shoulder Innovations can invest in research and development to create next-generation implants, surgical instruments, and software solutions that further improve biomechanics, reduce complications, and enhance patient outcomes. This could include incorporating advanced materials, such as porous titanium, and integrating smart technologies for real-time monitoring and feedback. The timeline for new product launches is estimated at 12-18 months, with a potential market size of $500 million.
- Strategic partnerships with hospitals and orthopedic clinics can accelerate adoption of Shoulder Innovations' products and expand its market reach. By collaborating with leading healthcare institutions, the company can gain access to a wider network of surgeons and patients, as well as opportunities to conduct clinical trials and showcase the benefits of its technology. These partnerships can also involve joint marketing initiatives, training programs, and bundled service offerings. The potential revenue impact from strategic partnerships is estimated at $100 million over the next three years.
- Leveraging digital technologies, such as 3D printing and virtual reality, can enhance the precision and personalization of shoulder replacement surgery. Shoulder Innovations can utilize 3D printing to create patient-specific implants and surgical guides, enabling surgeons to achieve more accurate and predictable results. Virtual reality can be used to train surgeons on the company's technology and simulate complex surgical procedures. The market for 3D-printed medical devices is projected to reach $6 billion by 2027, presenting a significant opportunity for Shoulder Innovations.
- Focusing on minimally invasive surgical techniques can attract a wider range of patients and surgeons. Minimally invasive procedures offer several advantages, including smaller incisions, reduced pain, faster recovery times, and lower risk of complications. Shoulder Innovations can develop specialized instruments and implants that are specifically designed for minimally invasive shoulder replacement surgery. The demand for minimally invasive orthopedic procedures is growing rapidly, driven by patient preferences and advancements in surgical technology. This approach could increase market penetration by 15% within the next two years.
Opportunities
- Expansion into new geographic markets.
- Development of new product lines and enhancements.
- Strategic partnerships with hospitals and orthopedic clinics.
- Leveraging digital technologies for personalized surgery.
Threats
- Competition from established players in the orthopedic device market.
- Stringent regulatory requirements and lengthy approval processes.
- Potential for product liability claims.
- Economic downturns and healthcare spending cuts.
Competitive Advantages
- Proprietary technology and intellectual property related to shoulder replacement systems.
- Strong relationships with orthopedic surgeons and healthcare providers.
- Focus on patient-specific solutions and personalized medicine.
- Commitment to innovation and continuous product development.
About SI
Shoulder Innovations, Inc., founded in 2009 by Stephen B. Gunther and Michael DeVries, is a medical device company focused on revolutionizing shoulder replacement surgery. Headquartered in Grand Rapids, MI, the company has dedicated itself to the design, development, and manufacturing of innovative shoulder replacement systems. Their flagship product is a novel shoulder replacement system engineered to improve biomechanics, reduce complications, and enhance patient outcomes. This system incorporates advanced materials and designs tailored to individual patient anatomy, aiming to restore natural shoulder function and alleviate pain. Shoulder Innovations' commitment extends beyond product development to include comprehensive surgical training and support, ensuring surgeons are well-equipped to utilize their technology effectively. The company operates primarily in the United States, targeting hospitals and orthopedic surgeons specializing in shoulder reconstruction. While still relatively small compared to industry giants, Shoulder Innovations is gaining traction through its focus on innovation, patient-specific solutions, and a commitment to improving the standard of care in shoulder arthroplasty. Their growth strategy involves expanding their product portfolio, increasing market penetration, and forging strategic partnerships within the healthcare industry. The company's unique approach and dedication to advancing shoulder replacement technology position them as a key player in the evolving orthopedic device landscape.
What They Do
- Designs and manufactures shoulder replacement systems.
- Develops patient-specific implants for improved fit and function.
- Provides surgical training and support to orthopedic surgeons.
- Offers a comprehensive solution for shoulder arthroplasty.
- Focuses on improving biomechanics and reducing complications.
- Utilizes advanced materials and designs in their products.
- Strives to restore natural shoulder function and alleviate pain.
Business Model
- Sells shoulder replacement systems to hospitals and orthopedic clinics.
- Generates revenue through the sale of implants, instruments, and related products.
- Provides surgical training and support services for a fee.
- Focuses on building long-term relationships with surgeons and healthcare providers.
Industry Context
Shoulder Innovations operates within the medical specialties industry, a segment of the broader healthcare sector. The market for orthopedic devices, including shoulder replacements, is experiencing steady growth driven by an aging population, increasing incidence of joint disorders, and advancements in surgical techniques. The competitive landscape includes established players like AARD (ArthroDynamic Technologies) and ASMB (Assembly Medical), as well as smaller, innovative companies. Shoulder Innovations differentiates itself through its focus on patient-specific solutions and advanced biomechanical designs. The industry is characterized by stringent regulatory requirements, high research and development costs, and a growing emphasis on minimally invasive procedures and personalized medicine. Shoulder Innovations is well-positioned to capitalize on these trends with its innovative technology and commitment to improving patient outcomes.
Key Customers
- Hospitals and medical centers performing orthopedic surgeries.
- Orthopedic surgeons specializing in shoulder reconstruction.
- Patients requiring shoulder replacement surgery.
- Healthcare providers seeking innovative and effective solutions.
Financials
Chart & Info
SHOULDER INNOVATIONS, INC. (SI) stock price: $14.30 (+0.00, +0.00%)
Latest News
-
Earnings Scheduled For March 10, 2026
benzinga · Mar 10, 2026
-
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
benzinga · Jan 17, 2023
-
Stocks That Hit 52-Week Lows On Monday
benzinga · Dec 12, 2022
-
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2022
benzinga · Jun 13, 2022
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SI.
Price Targets
Wall Street price target analysis for SI.
MoonshotScore
What does this score mean?
The MoonshotScore rates SI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Earnings Scheduled For March 10, 2026
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Stocks That Hit 52-Week Lows On Monday
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2022
Common Questions About SI
What does SHOULDER INNOVATIONS, INC. do?
Shoulder Innovations, Inc. is a medical device company specializing in the design, development, and manufacturing of innovative shoulder replacement systems. Their primary focus is on improving the biomechanics, reducing complications, and enhancing patient outcomes associated with shoulder arthroplasty. They achieve this through patient-specific implants and advanced surgical techniques, offering a comprehensive solution for orthopedic surgeons and patients seeking relief from shoulder pain and dysfunction. Their commitment extends to providing surgical training and support to ensure proper utilization of their technology.
Is SI stock worth researching?
SI stock presents a mixed picture for potential investors. The company's innovative technology and strong gross margin of 76.7% are positive indicators. However, the negative profit margin of -87.4% and a P/E ratio of -47.64 suggest that the company is currently unprofitable. Upcoming catalysts, such as new product launches and positive clinical trial data, could drive future growth. Investors should carefully consider the risks and potential rewards before investing, focusing on the company's ability to achieve profitability and gain market share.
What are the main risks for SI?
The main risks for Shoulder Innovations include intense competition from larger, more established players in the orthopedic device market, such as ArthroDynamic Technologies and Assembly Medical. Regulatory hurdles and potential delays in obtaining approvals for new products also pose a risk. The company's current unprofitability and reliance on external financing create financial risks. Additionally, the high beta of -7.48 indicates significant stock price volatility, making it a potentially risky investment. Product liability claims and recalls are also potential risks in the medical device industry.
What are the key factors to evaluate for SI?
SHOULDER INNOVATIONS, INC. (SI) currently holds an AI score of 59/100, indicating moderate score. Key strength: Innovative shoulder replacement system with improved biomechanics.. Primary risk to monitor: Potential: Competition from larger, more established players in the orthopedic device market.. This is not financial advice.
How frequently does SI data refresh on this page?
SI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven SI's recent stock price performance?
Recent price movement in SHOULDER INNOVATIONS, INC. (SI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative shoulder replacement system with improved biomechanics.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider SI overvalued or undervalued right now?
Determining whether SHOULDER INNOVATIONS, INC. (SI) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying SI?
Before investing in SHOULDER INNOVATIONS, INC. (SI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information. Stock data pending update.